Vector Group Ltd.
 

Filed pursuant to Rule 424(b)(3)
Registration No. 333-137093
PROSPECTUS SUPPLEMENT NO. 8 DATED SEPTEMBER 27, 2007
(to prospectus dated December 22, 2006)
VECTOR GROUP LTD.
3 7/8% Variable Interest Senior Convertible Debentures due June 15, 2026
and
Common Stock Issuable upon Conversion of the Debentures
 
     This prospectus supplement supplements the prospectus dated December 22, 2006 of Vector Group Ltd. relating to the sale by certain of our securityholders (and their transferees, pledgees, donees and successors) of our 3 7/8% Variable Interest Senior Convertible Debentures due June 15, 2026 and the common stock issuable upon conversion of the debentures. You should read this prospectus supplement in conjunction with the prospectus, and this prospectus supplement is qualified by reference to the prospectus, except to the extent that the information in this prospectus supplement supercedes the information contained in the prospectus.
     The table of selling securityholders contained on pages 65 to 70 of the prospectus is hereby amended to add the following additional selling securityholders.
                                             
                            Number of Shares        
                    Number of Shares of   of Common Stock        
    Principal Amount           Common Stock   that May Be Sold   Number of Shares of    
    of Debentures   Percentage of   Beneficially Owned   Pursuant To This   Common Stock   Percentage of
    Beneficially Owned   Debentures   Before This   Prospectus   Beneficially Owned   Common Stock
Name   that May Be Sold   Outstanding   Offering   (1)   After this Offering   Outstanding (2)
 
                                            
Citadel Equity Fund Ltd. (3)
  $ 3,000,000       2.7 %     0       153,847       0     *
 
*   Less than 1%.
 
(1)   Assumes conversion of all of the securityholders’ debentures at a conversion price of $19.50 per share of common stock. The conversion price is subject to adjustment as described under “Description of Debentures-Conversion Rights” and, as a result, the amount of common stock issuable upon conversion of the debentures may increase or decrease in the future.
 
(2)   Calculated based on Rule 13d-3(d)(i) of the Exchange Act using shares of common stock outstanding as of September 26, 2007. In calculating this amount, we treated as outstanding the number of shares of common stock issuable upon conversion of all of that particular securityholder’s debentures. We did not assume, however, the conversion of any other securityholder’s debentures.
 
(3)   Citadel Limited Partnership (“CLP”) is the trading manager of the selling security holder and has investment discretion over these securities. Citadel Investment Group, L.L.C. (“CIG”) controls CLP. Kenneth C. Griffin controls CIG and has ultimate investment discretion over these securities. CLP, CIG and Mr. Griffin each disclaim beneficial ownership of these securities. The selling securityholder has informed us that (i) it is an affiliate of Aragon Investments Ltd., Palofax Trading LLC, Citadel Trading Group, LLC and Citadel Derivatives Group, LLC, registered broker-dealers, (ii) it purchased the securities in the ordinary course of business, and (iii) at the time of purchase, the selling securityholder had no agreements or understandings, directly or indirectly, with any person to distribute the securities. The debentures shown in this prospectus supplement as owned by the selling securityholder are in addition to the $7,500,000 of debentures, convertible into 384,616 shares of our common stock, previously reported in this prospectus as owned by such holder.
 
     Investing in the debentures and our common stock involves risks, which are described under “Risk Factors” beginning on page 13 of the prospectus.
 
     Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is September 27, 2007.